Connection

JANICE NICOLE CORMIER to Neoplasm Staging

This is a "connection" page, showing publications JANICE NICOLE CORMIER has written about Neoplasm Staging.
Connection Strength

1.294
  1. Population-based assessment of surgical treatment trends for patients with melanoma in the era of sentinel lymph node biopsy. J Clin Oncol. 2005 Sep 01; 23(25):6054-62.
    View in: PubMed
    Score: 0.087
  2. An Evaluation of the Eighth Edition of the American Joint Committee on Cancer (AJCC) Staging System for Retroperitoneal Sarcomas Using the National Cancer Data Base (NCDB): Does Size Matter? Am J Clin Oncol. 2019 02; 42(2):160-165.
    View in: PubMed
    Score: 0.055
  3. Comparative Performance of the 7th and 8th Editions of the American Joint Committee on Cancer Staging Systems for Soft Tissue Sarcoma of the Trunk and Extremities. Ann Surg Oncol. 2018 May; 25(5):1126-1132.
    View in: PubMed
    Score: 0.051
  4. Defining the incidence and clinical significance of lymph node metastasis in soft tissue sarcoma. Eur J Surg Oncol. 2018 01; 44(1):170-177.
    View in: PubMed
    Score: 0.051
  5. A Cost Analysis of Preoperative Breast MRI Use for Patients with Invasive Lobular Cancer. Ann Surg Oncol. 2016 Jan; 23(1):23-9.
    View in: PubMed
    Score: 0.043
  6. Is surveillance imaging effective for detecting surgically treatable recurrences in patients with melanoma? A comparative analysis of stage-specific surveillance strategies. Ann Surg. 2014 Jun; 259(6):1215-22.
    View in: PubMed
    Score: 0.040
  7. Association between travel distance and metastatic disease at diagnosis among patients with colon cancer. J Clin Oncol. 2014 Mar 20; 32(9):942-8.
    View in: PubMed
    Score: 0.039
  8. Melanoma incidence rises for children and adolescents: an epidemiologic review of pediatric melanoma in the United States. J Pediatr Surg. 2013 Nov; 48(11):2207-13.
    View in: PubMed
    Score: 0.038
  9. Prospective assessment of lymphedema incidence and lymphedema-associated symptoms following lymph node surgery for melanoma. Melanoma Res. 2013 Aug; 23(4):290-7.
    View in: PubMed
    Score: 0.037
  10. Neuroendocrine tumors of the colon and rectum: prognostic relevance and comparative performance of current staging systems. Ann Surg Oncol. 2013 Apr; 20(4):1170-8.
    View in: PubMed
    Score: 0.036
  11. Adherence to stage-specific treatment guidelines for patients with colon cancer. J Clin Oncol. 2012 Mar 20; 30(9):972-9.
    View in: PubMed
    Score: 0.034
  12. Novel staging system for predicting disease-specific survival in patients with breast cancer treated with surgery as the first intervention: time to modify the current American Joint Committee on Cancer staging system. J Clin Oncol. 2011 Dec 10; 29(35):4654-61.
    View in: PubMed
    Score: 0.033
  13. Mapping FACT-melanoma quality-of-life scores to EQ-5D health utility weights. Value Health. 2011 Sep-Oct; 14(6):900-6.
    View in: PubMed
    Score: 0.032
  14. Validation of a novel staging system for disease-specific survival in patients with breast cancer treated with neoadjuvant chemotherapy. J Clin Oncol. 2011 May 20; 29(15):1956-62.
    View in: PubMed
    Score: 0.032
  15. Contemporary diagnostic imaging modalities for the staging and surveillance of melanoma patients: a meta-analysis. J Natl Cancer Inst. 2011 Jan 19; 103(2):129-42.
    View in: PubMed
    Score: 0.031
  16. Conditional survival estimates improve over 5 years for melanoma survivors with node-positive disease. Ann Surg Oncol. 2010 Aug; 17(8):2015-23.
    View in: PubMed
    Score: 0.030
  17. Minimal limb volume change has a significant impact on breast cancer survivors. Lymphology. 2009 Dec; 42(4):161-75.
    View in: PubMed
    Score: 0.029
  18. Management and outcomes of anorectal infection in the cancer patient. Ann Surg Oncol. 2009 Oct; 16(10):2752-8.
    View in: PubMed
    Score: 0.028
  19. Adjuvant high-dose interferon for cutaneous melanoma is most beneficial for patients with early stage III disease. Cancer. 2008 May 01; 112(9):2030-7.
    View in: PubMed
    Score: 0.026
  20. Pelvic lymph node dissection is beneficial in subsets of patients with node-positive melanoma. Ann Surg Oncol. 2007 Oct; 14(10):2867-75.
    View in: PubMed
    Score: 0.025
  21. Ethnic differences among patients with cutaneous melanoma. Arch Intern Med. 2006 Sep 25; 166(17):1907-14.
    View in: PubMed
    Score: 0.023
  22. Utility of computed tomography and magnetic resonance imaging staging before completion lymphadenectomy in patients with sentinel lymph node-positive melanoma. J Clin Oncol. 2006 Jun 20; 24(18):2858-65.
    View in: PubMed
    Score: 0.023
  23. Invasive squamous cell carcinoma of the skin: defining a high-risk group. Ann Surg Oncol. 2006 Jul; 13(7):902-9.
    View in: PubMed
    Score: 0.023
  24. Management of hepatocellular carcinoma. J Gastrointest Surg. 2006 May; 10(5):761-80.
    View in: PubMed
    Score: 0.023
  25. Assessment of the role of sentinel lymph node biopsy for primary cutaneous desmoplastic melanoma. Cancer. 2006 Feb 15; 106(4):900-6.
    View in: PubMed
    Score: 0.022
  26. Angiosarcoma of the breast. Cancer. 2005 Dec 15; 104(12):2682-8.
    View in: PubMed
    Score: 0.022
  27. Measuring quality of life in patients with melanoma: development of the FACT-melanoma subscale. J Support Oncol. 2005 Mar-Apr; 3(2):139-45.
    View in: PubMed
    Score: 0.021
  28. Cohort analysis of patients with localized, high-risk, extremity soft tissue sarcoma treated at two cancer centers: chemotherapy-associated outcomes. J Clin Oncol. 2004 Nov 15; 22(22):4567-74.
    View in: PubMed
    Score: 0.020
  29. Soft tissue sarcomas. CA Cancer J Clin. 2004 Mar-Apr; 54(2):94-109.
    View in: PubMed
    Score: 0.020
  30. Cumulative Incidence and Predictors of CNS Metastasis for Patients With American Joint Committee on Cancer 8th Edition Stage III Melanoma. J Clin Oncol. 2020 05 01; 38(13):1429-1441.
    View in: PubMed
    Score: 0.015
  31. Role of Immune Response, Inflammation, and Tumor Immune Response-Related Cytokines/Chemokines in Melanoma Progression. J Invest Dermatol. 2019 11; 139(11):2352-2358.e3.
    View in: PubMed
    Score: 0.014
  32. Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma. Nat Med. 2018 11; 24(11):1649-1654.
    View in: PubMed
    Score: 0.013
  33. Phase II study of neoadjuvant checkpoint blockade in patients with surgically resectable undifferentiated pleomorphic sarcoma and dedifferentiated liposarcoma. BMC Cancer. 2018 Sep 24; 18(1):913.
    View in: PubMed
    Score: 0.013
  34. Neoadjuvant plus adjuvant dabrafenib and trametinib versus standard of care in patients with high-risk, surgically resectable melanoma: a single-centre, open-label, randomised, phase 2 trial. Lancet Oncol. 2018 02; 19(2):181-193.
    View in: PubMed
    Score: 0.013
  35. Adherence to National Comprehensive Cancer Network Guidelines is Associated with Improved Survival for Patients with Stage 2A and Stages 2B and 3 Extremity and Superficial Trunk Soft Tissue Sarcoma. Ann Surg Oncol. 2017 Oct; 24(11):3271-3278.
    View in: PubMed
    Score: 0.012
  36. Health Disparities Influence Childhood Melanoma Stage at?Diagnosis?and?Outcome. J Pediatr. 2016 08; 175:182-7.
    View in: PubMed
    Score: 0.011
  37. Cost-Effectiveness of Chemotherapy for Breast Cancer and Age Effect in Older Women. Value Health. 2015 Dec; 18(8):1070-8.
    View in: PubMed
    Score: 0.011
  38. Adequacy of the National Quality Forum's Colon Cancer Adjuvant Chemotherapy Quality Metric: Is 4 Months Soon Enough? Ann Surg. 2015 Aug; 262(2):312-20.
    View in: PubMed
    Score: 0.011
  39. Accuracy of preoperative percutaneous biopsy for the diagnosis of retroperitoneal liposarcoma subtypes. Ann Surg Oncol. 2015 Apr; 22(4):1068-72.
    View in: PubMed
    Score: 0.010
  40. Risk-adjusted pathologic margin positivity rate as a quality indicator in rectal cancer surgery. J Clin Oncol. 2014 Sep 20; 32(27):2967-74.
    View in: PubMed
    Score: 0.010
  41. Analysis of prognostic factors impacting oncologic outcomes after neoadjuvant tyrosine kinase inhibitor therapy for gastrointestinal stromal tumors. Ann Surg Oncol. 2014 Aug; 21(8):2499-505.
    View in: PubMed
    Score: 0.010
  42. Cost-utility analysis of platinum-based chemotherapy versus taxane and other regimens for ovarian cancer. Value Health. 2014 Jan-Feb; 17(1):34-42.
    View in: PubMed
    Score: 0.010
  43. Phase 1 prospective evaluation of the oncological adequacy of robotic assisted video-endoscopic inguinal lymphadenectomy in patients with penile carcinoma. BJU Int. 2013 Jun; 111(7):1068-74.
    View in: PubMed
    Score: 0.009
  44. Assessing the utility of cancer-registry-processed cause of death in calculating cancer-specific survival. Cancer. 2013 May 15; 119(10):1900-7.
    View in: PubMed
    Score: 0.009
  45. Long-term outcomes in patients with radiation-associated angiosarcomas of the breast following surgery and radiotherapy for breast cancer. Ann Surg Oncol. 2013 Apr; 20(4):1267-74.
    View in: PubMed
    Score: 0.009
  46. Other primary malignancies in breast cancer patients treated with breast conserving surgery and radiation therapy. Ann Surg Oncol. 2013 May; 20(5):1514-21.
    View in: PubMed
    Score: 0.009
  47. A population-based study of the quality of care in the diagnosis of large (=5 cm) soft tissue sarcomas. Am J Clin Oncol. 2012 Oct; 35(5):455-61.
    View in: PubMed
    Score: 0.009
  48. Sentinel lymph node biopsy for melanoma: American Society of Clinical Oncology and Society of Surgical Oncology joint clinical practice guideline. J Clin Oncol. 2012 Aug 10; 30(23):2912-8.
    View in: PubMed
    Score: 0.009
  49. Sentinel lymph node biopsy for melanoma: American Society of Clinical Oncology and Society of Surgical Oncology joint clinical practice guideline. Ann Surg Oncol. 2012 Oct; 19(11):3313-24.
    View in: PubMed
    Score: 0.009
  50. Clinicopathology and outcomes for mucinous and signet ring colorectal adenocarcinoma: analysis from the National Cancer Data Base. Ann Surg Oncol. 2012 Sep; 19(9):2814-21.
    View in: PubMed
    Score: 0.009
  51. PET/CT in the management of patients with stage IIIC and IV metastatic melanoma considered candidates for surgery: evaluation of the additive value after conventional imaging. AJR Am J Roentgenol. 2012 Apr; 198(4):902-8.
    View in: PubMed
    Score: 0.009
  52. Risk of xerostomia in association with the receipt of radiation therapy in older patients with head and neck cancer. Am J Ther. 2011 May; 18(3):206-15.
    View in: PubMed
    Score: 0.008
  53. Cardiac toxicity in association with chemotherapy and radiation therapy in a large cohort of older patients with non-small-cell lung cancer. Ann Oncol. 2010 Sep; 21(9):1825-1833.
    View in: PubMed
    Score: 0.007
  54. Chemotherapy-associated toxicity in a large cohort of elderly patients with non-small cell lung cancer. J Thorac Oncol. 2010 Jan; 5(1):90-8.
    View in: PubMed
    Score: 0.007
  55. Complete soft tissue sarcoma resection is a viable treatment option for select elderly patients. Ann Surg Oncol. 2009 Sep; 16(9):2579-86.
    View in: PubMed
    Score: 0.007
  56. Incidence, treatment costs, and complications of lymphedema after breast cancer among women of working age: a 2-year follow-up study. J Clin Oncol. 2009 Apr 20; 27(12):2007-14.
    View in: PubMed
    Score: 0.007
  57. Attempted salvage resection for recurrent gastric or gastroesophageal cancer. Ann Surg Oncol. 2009 Jan; 16(1):42-50.
    View in: PubMed
    Score: 0.007
  58. Staging of breast cancer in the neoadjuvant setting. Cancer Res. 2008 Aug 15; 68(16):6477-81.
    View in: PubMed
    Score: 0.007
  59. Does neoadjuvant treatment for gastric cancer patients with positive peritoneal cytology at staging laparoscopy improve survival? Ann Surg Oncol. 2008 Oct; 15(10):2684-91.
    View in: PubMed
    Score: 0.007
  60. Long-term survival after radical prostatectomy compared to other treatments in older men with local/regional prostate cancer. J Surg Oncol. 2008 Jun 01; 97(7):583-91.
    View in: PubMed
    Score: 0.007
  61. Lymphadenectomy for isolated lymph node metastasis from extremity soft-tissue sarcomas. Cancer. 2008 Apr 15; 112(8):1821-6.
    View in: PubMed
    Score: 0.006
  62. Combined use of clinical and pathologic staging variables to define outcomes for breast cancer patients treated with neoadjuvant therapy. J Clin Oncol. 2008 Jan 10; 26(2):246-52.
    View in: PubMed
    Score: 0.006
  63. The effect of preoperative radiotherapy and reconstructive surgery on wound complications after resection of extremity soft-tissue sarcomas. Ann Surg Oncol. 2006 Sep; 13(9):1209-15.
    View in: PubMed
    Score: 0.006
  64. Racial disparity and socioeconomic status in association with survival in older men with local/regional stage prostate carcinoma: findings from a large community-based cohort. Cancer. 2006 Mar 15; 106(6):1276-85.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.